Familial Non-Medullary Thyroid Carcinoma: Distinct Clinicopathological Features and Prognostic Implications in a Large Cohort of 46,572 Patients
Cancers · 20.10.2025 · 17 (20) · 3381
DOI: 10.3390/cancers17203381 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 20.10.2025. Verfasst von Cho Rok Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin-si 16995, Republic of Korea. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yonsei University College of Medicine.
Abstract (Originalsprache)
Background
The incidence of thyroid cancer has rapidly increased worldwide, and familial aggregation of the disease has been increasingly recognized. This study aimed to evaluate the prevalence, clinicopathological characteristics, and long-term outcomes of familial non-medullary thyroid cancer (FNMTC) in a large institutional cohort.
Methods
Patients with non-medullary thyroid cancer (NMTC) who had undergone surgery were classified as sporadic NMTC (SNMTC) or FNMTC based on family history. Clinicopathological features at diagnosis and surgery were compared, and prognostic outcomes were analyzed in patients with follow-up data.
Results
Among the 46,572 NMTC patients, 3829 (8.2%) had FNMTC, and 42,743 (91.8%) had SNMTC. FNMTC was more prevalent in women and occurred at a younger age. Its proportion increased over time, peaking in the 35–59 age group. FNMTC showed higher rates of bilaterality (23.5% vs. 17.5%, p < 0.001), multifocality (39.0% vs. 30.5%, p < 0.001), and central lymph node metastasis (41.5% vs. 38.8%, p = 0.001), despite smaller tumors (0.9 ± 0.7 cm vs. 1.0 ± 0.9 cm, p < 0.001). Recurrence rates were similar between the two groups (1.9% vs. 2.3%, p = 0.1), but overall survival was higher in the FNMTC group (99.6% vs. 98.6%, p < 0.001). Family history, extracapsular extension, lymph node metastasis, and tumor size independently predicted recurrence. Family history significantly impacted recurrence-free survival in the intermediate-to-high-risk group (HR = 1.65, p < 0.001) but not in low-risk patients.
Conclusions
FNMTC represents a distinct NMTC subset with more extensive local disease but favorable survival, warranting risk-adapted management, particularly for intermediate-to-high-risk patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin-si 16995, Republic of Korea.
- Department of Surgery, Severance Hospital, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
ORCID-Profile: Cho Rok Lee, Sang-Wook Kang, Jandee Lee, Jong Ju Jeong
Förderung
- Yonsei University College of Medicine
Zitieren
APA
Lee, C. R., Kim, J. K., Ho, J., Kang, S. W., Lee, J., Jeong, J. J., Nam, K. H., & Chung, W. Y. (2025). Familial Non-Medullary Thyroid Carcinoma: Distinct Clinicopathological Features and Prognostic Implications in a Large Cohort of 46,572 Patients. Cancers, 17(20), 3381. https://doi.org/10.3390/cancers17203381
Vancouver
Lee CR, Kim JK, Ho J, Kang SW, Lee J, Jeong JJ, et al. Familial Non-Medullary Thyroid Carcinoma: Distinct Clinicopathological Features and Prognostic Implications in a Large Cohort of 46,572 Patients. Cancers. 2025;17(20):3381. doi:10.3390/cancers17203381
BibTeX
@article{Lee2025,
author = {Lee, Cho Rok and Kim, Jin Kyong and Ho, Joon and Kang, Sang-Wook and Lee, Jandee and Jeong, Jong Ju and Nam, Kee-Hyun and Chung, Woong Youn},
title = {Familial Non-Medullary Thyroid Carcinoma: Distinct Clinicopathological Features and Prognostic Implications in a Large Cohort of 46,572 Patients},
journal = {Cancers},
year = {2025},
volume = {17},
number = {20},
pages = {3381},
doi = {10.3390/cancers17203381}
}
EUVIMED